NuVasive preliminary 2015 revenue hits $811M: 5 key notes

Spinal Tech

NuVasive reported preliminary full-year 2015 financial results and the outlook for this coming year.

Here are five key notes:

 

1. NuVasive anticipates revenue will reach around $811 million in 2015, a 6 percent increase over 2014. This is close to the $810 million the company previously issued as guidance for the full year.

 

2. In the fourth quarter, NuVasive anticipates reaching $215 million.

 

3. NuVasive expects the full year 2015 non-GAAP operating profit margin to exceed the previous financial performance guidance of around 15.2 percent.

 

4. NuVasive recently acquired Ellipse Technologies, driving company growth. Margin expansion is expected as the company reaches past $1 billion in revenue.

 

5. The Ellipse Technologies transaction is expected to close in February 2016 and NuVasive expects to update its full year and long-term financial performance guidance to reflect the acquisition.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers